Q: I have reading a lot of GE planned Spin Off's and would like to know your thoughts on whether to continue to own shares of GE and the new entities after the new companies have been launched?
Q: I recently picked up some POWL:US stock. Today (Friday March 1st) I see the stock has dropped approx 5%. I also note that Mr. T Powell, owner, sold 25K shares. This might have been a trigger for some investors as a time to sell. However, he owns 2.4M shares. I am thinking that his sale is actually immaterial to his overall holdings. In other words, this might be a good time to purchase more. Am I on the right track?
My thanks.
Interested in your perspective on CDRs vs traditional US holdings. Understanding you are comfortable with them did want to validate 2 scenarios -
1 - Would you always prefer the traditional US holding versus its equivalent CDR and assuming so - is there a minimun you would consider in terms of holdings. Simply put - does it make sense to buy only (example) 3 shares of GOOG or should I instead use that liquidity to purchase equivalent CDR's
I bought this ARKK ETF during the pandemic time ARKK's hype days. As of today, many stocks recovered from 2023 lows, but ARKK. I am kind of losing patience, especially watching their daily trade information they published, keeping buying losers and selling winners. May I have your view on this ETF? Hold or move on? Thank you.
Q: Is the drop in these 3 is a buying opportunity or is it something more concerning regarding the business and outlook. Would you be OK to stay put or add or sell some. Thanks
Q: My question is about the special/unique/dynamic etc CEOs Michael Dell and Ryan Cohen. What is your estimation of each in respect to both DELL and GME. Different trajectories and challenges but curious on your insights about their management and decisions in the last couple of years etc thanks.
Q: Looking for advice on how to rank these 3 stocks for a medium-term investment. All seem solid based on past performance and metrics but not sure if any have a particular advantage given their respective foci and expansion potential.
What are your views on Altimmune (ALT-Q) and its growth prospects, its risks ? Would you buy it now for a growth account in a TFSA ? Which entry price would you suggest ?
What is your analysis of WAB and of its future prospects ? What would you compare it to in the same sector ? Would you buy it now for a growth portfolio in a TFSA ?
Q: Do you see the recent dip in PGNY as an opportunity or did the recent results indicate something worrying? Do you agree with the assessment that there could be long-term, above-average growth possibilities and PGNY is emerging as a leader rather than just simply another OK investment?
Q: Can you comment on todays news of takeover of Spirent and what it can mean going forward. Market seems to like it. What's your take? Is it a good buy?